Loading...
Rising Regulations And Fierce Competition Will Impede Clinical Sequencing
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-7.7%7D
-0.9%1Y
-7.7%7D
-0.9%You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.
You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.
Author's Valuation
AnalystLowTarget Fair Value